Adam C. Yopp

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Agnieszka K. Witkiewicz, Elizabeth A. McMillan, Uthra Balaji et al. · Nature Communications · 2015 · 1.1K citations · Full text

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott et al. · Journal of the National Comprehensive Cancer Network · 2021 · 999 citations · Full text

Surgical Oncology, Cancer Management, Pathology +22

TGF-β Induces Foxp3 + T-Regulatory Cells from CD4 + CD25 − Precursors

Shuang Fu, Nan Zhang, Adam C. Yopp et al. · American Journal of Transplantation · 2004 · 536 citations

Developmental Biology, Signal Transduction, Lymphocyte Development +14

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis

Ali A. Mokdad, Rebecca M. Minter, Hong Zhu et al. · Journal of Clinical Oncology · 2016 · 393 citations

Neoadjuvant Therapy Followed, Surgical Oncology, Pancreatic Cancer +13